Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucosylceramide synthase and apoptosis.

Richard J Bleicher1, Myles C Cabot

  • 1Breast Cancer Program, The John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90403, USA.

Biochimica Et Biophysica Acta
|January 18, 2003
PubMed
Summary

Glucosylceramide synthase (GCS) plays a key role in cancer cell response to chemotherapy. Blocking GCS enhances chemotherapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Sentinel Node Surgery in Identifying Candidates for Adjuvant CDK4/6 Inhibitors: Implications of Choosing Wisely and ASCO Omission Criteria.

Annals of surgical oncology·2026
Same author

"Going Flat" After Mastectomy: A Social Media Analysis of Patient Perspectives and Educational Needs.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

Impact of axillary surgery on survival in de novo metastatic breast cancer with primary tumor resection.

Breast cancer research and treatment·2026
Same author

Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia.

Blood neoplasia·2026
Same author

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Haematologica·2026

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Glucosylceramide synthase (GCS) is a key enzyme in ceramide metabolism, catalyzing the initial step in glycolipid biosynthesis.
  • GCS acts as a branch point enzyme, directing the synthesis of complex glycolipids like cerebrosides and gangliosides.
  • Recent findings implicate GCS in the cellular response to chemotherapy, particularly concerning apoptosis signaling.

Purpose of the Study:

  • To review the regulatory mechanisms of ceramide metabolism.
  • To highlight the role of Glucosylceramide synthase (GCS) in cancer cell cytotoxicity.
  • To discuss the impact of GCS activity on chemotherapy response.

Main Methods:

  • Literature review of ceramide metabolism and GCS function.
  • Analysis of studies investigating GCS activity and chemotherapy outcomes.
  • Synthesis of current knowledge on GCS as a therapeutic target.

Main Results:

  • GCS activity is a critical determinant of cancer cell sensitivity to chemotherapy.
  • Elevated GCS activity can impair the cytotoxic effects of chemotherapy.
  • Inhibition of GCS activity potentiates chemotherapy-induced apoptosis.

Conclusions:

  • GCS is a crucial regulator of the cytotoxic response to chemotherapy in cancer cells.
  • Modulating GCS activity presents a potential strategy to enhance chemotherapy efficacy.
  • Further research into GCS control points may reveal novel therapeutic avenues.

Related Experiment Videos